| ACE2 | Angiotensin-converting enzyme 2 |
| ADP | Adenosine diphosphate |
| AISI | Aggregate index of systemic inflammation |
| AKI | Acute kidney injury |
| ALRTI | Acute lower respiratory tract infection |
| ARDS | Acute respiratory distress syndrome |
| AUC | Area under the curve |
| BLR | Basophil-to-lymphocyte ratio |
| BP | Bordetella pertussis |
| cAMP | Cyclic adenosine monophosphate |
| CAP | Community-acquired pneumonia |
| CARDS | Community-acquired respiratory distress syndrome |
| CBC | Complete blood count |
| CCL2 | C-C motif chemokine ligand 2 |
| CD4 | Cluster of differentiation 4 |
| CD8 | Cluster of differentiation 8 |
| CI | Confidence interval |
| COVID-19 | Coronavirus disease 2019 |
| CRP | C-reactive protein |
| CXCL10 | C-X-C motif chemokine ligand 10 |
| CXCL8 | C-X-C motif chemokine ligand 8 |
| CXR | Chest X-ray |
| DNA | Deoxyribonucleic acid |
| dNLR | Derived neutrophil-to-lymphocyte ratio |
| EBV | Epstein–Barr virus |
| ELR | Eosinophil-to-lymphocyte ratio |
| EMR | Eosinophil-to-monocyte ratio |
| H1N1 | Influenza A virus subtype H1N1 |
| H3N2 | Influenza A virus subtype H3N2 |
| HAdV | Human adenovirus |
| HAP | Hospital-acquired pneumonia |
| HC | Healthy control |
| HIV | Human immunodeficiency virus |
| HMPV | Human metapneumovirus |
| HPIV | Human parainfluenza virus |
| HR | Hazard ratio |
| ICU | Intensive care unit |
| IFN-α | Interferon alpha |
| IFN-β | Interferon beta |
| IFN-γ | Interferon gamma |
| IGRA | Interferon-gamma release assay |
| IL-1β | Interleukin-1 beta |
| IL-33 | Interleukin-33 |
| IL-6 | Interleukin-6 |
| IL-8 | Interleukin-8 |
| InfA | Influenza A |
| InfB | Influenza B |
| IQR | Interquartile range |
| IRF3 | Interferon regulatory factor 3 |
| IRF7 | Interferon regulatory factor 7 |
| LMR | Lymphocyte-to-monocyte ratio |
| LNR | Lymphocyte-to-neutrophil ratio |
| LOS | Length of stay |
| LPR | Lymphocyte-to-platelet ratio |
| LRTI | Lower respiratory tract infection |
| LUS | Lung ultrasound |
| LYM*PLT | Lymphocyte multiplied by platelet |
| MBI | Mixed bacterial infection |
| MLR | Monocyte-to-lymphocyte ratio |
| MP | Mycoplasma pneumoniae |
| MPI | Mixed pathogen infection |
| MPP | Mycoplasma pneumoniae pneumonia |
| MPVLR | Mean platelet volume-to-lymphocyte ratio |
| MPV/PLT | Mean platelet volume-to-platelet count |
| MTB | Mycobacterium tuberculosis |
| MVI | Mixed viral infection |
| MyD88 | Myeloid differentiation primary response 88 |
| NEUT% | Neutrophil percentage |
| NF-κB | Nuclear factor kappa B |
| NK | Natural killer |
| NLPR | Neutrophil-to-lymphocyte-platelet ratio |
| NLR | Neutrophil-to-lymphocyte ratio |
| NMLR | Neutrophil-monocyte-to-lymphocyte ratio |
| NMR | Neutrophil-to-monocyte ratio |
| NP | Necrotizing pneumonia |
| NPR | Neutrophil-to-platelet ratio |
| NPV | Negative predictive value |
| OM | Otitis media |
| OR | Odds ratio |
| PB | Plastic bronchitis |
| PCR | Polymerase chain reaction |
| PCT | Procalcitonin |
| PICU | Pediatric intensive care unit |
| PLR | Platelet-to-lymphocyte ratio |
| PNR | Platelet-to-neutrophil ratio |
| PPV | Positive predictive value |
| PRESS | Pediatric respiratory severity score |
| RBC | Red blood cell |
| RMPP | Refractory Mycoplasma pneumoniae pneumonia |
| RNA | Ribonucleic acid |
| RR | Relative risk |
| RSV | Respiratory syncytial virus |
| RT-PCR | Reverse transcription polymerase chain reaction |
| SAA | Serum amyloid A |
| SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 |
| SC2 | SARS-CoV-2 |
| SII | Systemic immune-inflammation index |
| SIRI | Systemic inflammatory response index |
| SMPP | Severe Mycoplasma pneumoniae pneumonia |
| SP | Streptococcus pneumoniae |
| SPP | Streptococcus pneumoniae pneumonia |
| TB | Tuberculosis |
| Th2 | T helper type 2 |
| TLR2 | Toll-like receptor 2 |
| TMPRSS2 | Transmembrane serine protease 2 |
| TNF-α | Tumor necrosis factor alpha |
| URTI | Upper respiratory tract infection |
| VP | Viral pneumonia |
| WBC | White blood cell |
| YKL-40 | Chitinase-3-like protein 1 |